OMN6 a novel bioengineered peptide for the treatment of multidrug resistant Gram negative bacteria
Abstract New antimicrobial agents are urgently needed, especially to eliminate multidrug resistant Gram-negative bacteria that stand for most antibiotic-resistant threats. In the following study, we present superior properties of an engineered antimicrobial peptide, OMN6, a 40-amino acid cyclic pept...
Saved in:
Main Authors: | Shira Mandel, Janna Michaeli, Noa Nur, Isabelle Erbetti, Jonathan Zazoun, Livia Ferrari, Antonio Felici, Moshe Cohen-Kutner, Niv Bachnoff |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/83a72ed367e14c80809b6afdced28df3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Multidrug Efflux Inhibitors for Gram-Negative Bacteria
by: Robert L. Marshall, et al.
Published: (2020) -
Bioengineering
Published: (2014) -
La máxima "Quod omnes tangit": Una aproximación al estado del tema
by: Merello Arecco,Italo
Published: (2005) -
Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli.
by: Sayran Hamad Haji, et al.
Published: (2021) -
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
by: Yves Briers, et al.
Published: (2014)